Home/Filings/4/0001104659-25-006845
4//SEC Filing

Roberts M Scot 4

Accession 0001104659-25-006845

CIK 0001326190other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 9:06 PM ET

Size

23.6 KB

Accession

0001104659-25-006845

Insider Transaction Report

Form 4
Period: 2025-01-25
Roberts M Scot
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2025-01-25+14,60057,910 total
  • Award

    Stock Options (option to buy)

    2025-01-27+183,600183,600 total
    Exercise: $7.00Exp: 2035-01-27Common Stock, par value $0.0001 (183,600 underlying)
  • Tax Payment

    Common Stock, par value $0.0001

    2025-01-25$6.98/sh4,264$29,76353,646 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-25+14,60043,800 total
    Common Stock, par value $0.0001 (14,600 underlying)
  • Award

    Restricted Stock Units

    2025-01-27+63,40063,400 total
    Common Stock, par value $0.0001 (63,400 underlying)
Holdings
  • Common Stock, par value $0.0001

    (indirect: By Spouse)
    15
Footnotes (5)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
  • [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
  • [F3]The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
  • [F4]Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date.
  • [F5]The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001705905

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:06 PM ET
Size
23.6 KB